Modern compute-heavy projects place demands on infrastructure that standard servers cannot satisfy. Artificial intelligence ...

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA therapeutics for the treatment of high risk and advanced cancer, today announced the ...

TransCode Therapeutics ( ($RNAZ) ) just unveiled an update. On January 6, 2026, TransCode Therapeutics announced the publication in the Journal of ...

So long as you choose the right client for the job, your NAS can simply send the file over to the TV, tablet, or streaming ...

To support VIP at true sports scale, we needed a reliable and flexible live-video workflow foundation—in 2025 alone, we ...

BOSTON - TransCode Therapeutics, Inc. (NASDAQ:RNAZ), a clinical stage company focused on immuno-oncology and RNA treatments for advanced cancer, announced Monday the appointment of Jack E. Stover to ...

There’s really no benefit to leaving drives spun up 24/7 in a homelab environment. Your drives will typically last longer and ...

BOSTON, Dec. 22, 2025 /PRNewswire/ -- TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a clinical stage company pioneering immuno-oncology and RNA for the treatment of high risk and advanced cancer, ...

Aiarty reinforces responsible innovation with offline desktop AI tools where image and video processing occurs locally.

Investing.com -- TransCode Therapeutics (NASDAQ:RNAZ) stock surged 18% on Tuesday after the company published preclinical data showing its lead candidate TTX-MC138 demonstrated therapeutic potential ...

Publishes Preclinical Data Supporting TTX-MC138 For Glioblastoma. TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead ...